Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery

Journal of Controlled Release

Volumn 43, Issue 2-3, 1997, Pages 197-212

  Song, C X ^a   Labhasetwar, V ^a   Murphy, H ^a   Qu, X ^a   Humphrey, W R ^b   Shebuski, R J ^b   Levy, R J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b PFIZER INC   (United States)

Author keywords

Arterial uptake; Biodegradable; Ex vivo model; Nanoparticles; Restenosis

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; BOVINE SERUM ALBUMIN; CIPROSTENE; DEXAMETHASONE; NANOPARTICLE; POLYGLACTIN; U 86983; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STERILITY; EVAPORATION; PARTICLE SIZE; PRIORITY JOURNAL; TECHNIQUE;

EID: 0031060457     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01484-8     Document Type: Article

References (43)

1. J.P. Benoit and F. Puisieux, Microcapsules and microspheres for embolization and chemoembolization, in: P. Guiot and P. Couvreur (Eds.), Polymeric Nanoparticles and Microspheres, CRC Press, Boca Raton, FL, 1986. pp. 143.
2. J. Kreuter, Nanoparticles-preparation and application, in: M. Donbrow (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 125-148.
3. V. Labhasetwar, C. Song and R.J. Levy, Nanoparticle drug delivery system for restenosis. Adv. Drug Delivery Rev. in press.
4. J.J. Rome, V. Shayani, M.Y. Flugelman, K.D. Newman, A. Farb, R. Virmani and D.A. Dichek, Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Aterioscler. Thromb. 14 (1994) 148-161.
5. P. Jani, G.W. Halbert, J. Langridge and A.T. Florence, The uptake and translocation of latex nanoparticles and microspheres after oral administration to rats. J. Pharm. Pharmacol. 40 (1989) 809-812.
6. P. Jani, G.W. Halbert, J. Langridge and A.T. Florence, Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 41 (1990) 821-826.
7. A. Sanchez, J.L. Vila-Jato and M.J. Alonso, Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A. Int. J. Pharmaceutics 99 (1993) 263-267.
8. H. Sah, R. Toddywala and Y.W. Chien, Continuous release of protein from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant. J. Control. Release 35 (1995) 137-144.
9. T.R. Tice and S.E. Tabibi, Parenteral drug delivery: injectables, in: A. Kydonieus (Ed.), Treatise on Controlled Drug Delivery, Marcel Dekker, New York, NY, 1992, pp. 319-326.
10. T.M. Whateley, Biodegradable microspheres for controlled drug delivery, in: D.R. Karsa and R.A. Stephenson (Eds.). Encapsulation and Controlled Release, The Royal Society of Chemistry, Thomas Graham Hoise, Science Park, Cambridge, 1993, pp. 53-65.
11. R.H. Muller (Ed.), Colloidal Carriers for Controlled Drug Delivery and Targeting, CRC Press, Boca Raton, FL, 1991, pp. 1-16.
12. K.L. March, S. Mohanraj, P.P.K. Ho, R.L. Wilensky and D.R. Hathaway, Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. Circulation 89 (1994).
13. L.A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A.M. Lincoff and R.J. Levy, Single intraluminal infusion of biodegradable polymeric nanoparticles matrixed with dexamethasone decreases neointimal formation after vascular injury (abstract). Circulation 92 (1995) 1-293.
14. L.A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A.M. Lincoff, R.J. Levy and E.J. Topol, Local infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty. Circulation in press.
15. V. Labhasetwar, C. Song, W.R. Humphrey, R.J. Shebuski and R.J. Levy, Nanoparticles for site specific delivery of U86983 in restenosis in pig coronary arteries (abstract). Proceedings of the 22nd International Symposium on Controlled Release of Bioactive Materials, Published by Controlled Release Society, Deerfield, IL, USA, 1995, pp. 182-183.
16. A. Colin de Verdiere, C. Dubernet, F. Nemati, M.F. Poupon, F. Puisieux and P. Couvreur, Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother. Pharmacol. 33 (1994) 504-508.
17. P. Couvreur, L. Grislain, V. Lenaerts, F. Brasseur, P. Guiot and A. Biernacki, Biodegradable polymeric nanoparticles as drug carrier for antitumor agents, in: P. Guiot and P. Couvreur (Eds.), Polymeric Nanoparticles and Microspheres, CRC Press, Boca Raton, FL, 1986, pp. 27-94.
18. S. Cohen, T. Yshioka, M. Lucarelli, L.H. Hwaug and R. Langer, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8 (1991) 713-720.
19. H. Okada, Y. Ogawa and T. Yashiki, Prolonged release microcapsules and its production, U.S. Patent 4,652,441, 24 March 1987.
20. H. Jeffery, S.S. Davis and D.T. O'Hagan, The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10(3) (1993) 362-368.
21. P. Couvreur and F. Puisieux, Nano- and microparticles for the delivery of polypeptides and proteins. Adv. Drug Delivery Rev. 10 (1993) 141-162.
22. T. Uchida, S. Martin, T.P. Foster, R.C. Wardley and S. Grimm, Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm. Res. 11(7) (1994) 1009-1015.
23. T. Niwa, H. Takeuchi, T. Hino, N. Kunou and Y. Kawashima, Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J. Control. Release 25(1) (1993) 89-98.
24. C.G. Pitt, The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm. 59 (1990) 173-196.
25. [25| R. Langer, New methods of drug delivery. Science 249 (1990) 1527-1533.
26. R. Langer and J. Folkman, Polymers for the sustained release of proteins and other macromolecules. Nature 263 (1976) 797-800.
27. [27[ R.A. Kenley, M.O. Lee, T.R. Mahoney II and L.M. Sanders, Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro. Macromolecule 20 (1987) 2398-2403.
28. P.P. DeLuca, R.C. Mehta, A.G. Hausberger and B.C. Thanoo, Biodegradable polyesters for drug and polypeptide delivery, in: M.A. El-Nokaly, D.M. Piatt and B.A. Charpentier (Eds.), Polymeric Delivery Systems: Properties and Applications, 1993, pp. 53-79.
29. S.S. Shah, Y. Cha and C.G. Pitt, Poly(glycolic acid-co-DL-lactic acid): diffusion or degradation controlled drug delivery? J. Control. Release 18 (1992) 261-270.
30. C. Thies, Formation of degradable drug loaded microparti-cles by in-liquid processes, in: M. Donbrow (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 47-72.
31. P.B. Deasy, M.R. Brophy, B. Ecanow and M.M. Joy, Effect of ethylcellulose grade and sealant treatments on the production and in vitro release of microencapsulated sodium salicylate. J. Pharm. Pharmacol. 32 (1980) 15.
32. T. Siki and Y. Okahata, Controlled release from a large capsule membrane corked with phosphatidylethanolamine bilayers: effect of temperature, pH and concentration of Ca + 2 ion. J. Microencaps. 2 (1985) 13.
33. A. Villa, L. Guzman, W. Chen, G. Golomb, R. Levy and E. Topol, Local delivery of dexamethasone for prevention of neointimal proliferation in rat model of balloon angioplasty. J. Clin. Invest. 93 (1994) 1243-1249.
34. H.V. Maulding, T.R. Tice, D.R. Cowsar, J.W. Fang, J.E. Pearson and J.R. Nazareno, Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J. Control. Release 3 (1986) 103.
35. M. Vert, J. Mauduit and S. Li, Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials 15(15) (1994) 1209-1213.
36. C.G. Pitt, M.M. Gratzl, G.L. Kimmel, J. Surles and A. Schindler, Aliphatic polyesters. II. The degradation of poly-(dl-lactide), poly (∈-caprolactone) and their copolymers in vivo. Biomaterials 2 (1981) 215-220.
37. L. Manil, J. Davin, C. Duchenne, C. Kubiak, J. Foidart, P. Couvreur and P. Mahieu, Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro. Pharm. Res. 11(8) (1994) 1160-1167.
38. R.C. Oppenheim, Nanoparticle drug delivery systems based on gelatin and albumin, in: P. Guiot and P. Couvreur (Eds.), Polymeric Nanoparticles and Microspheres, CRC Press, Boca Raton, Florida, 1986, pp. 1-25.
39. S.S. Davis and L. Illum, Colloidal delivery systems opportunities and challenges, in: E. Tomlinson and S.S. Davis (Eds.), Site-Specific Drug Delivery, John Wiley, New York, 1986, pp. 93-110.
40. J.J. Wright and L. Illum, Active targeting of microcapsules and microspheres to specific regions, in: M. Donbrow (Ed.). Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 282-293.
41. D.H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers, in: M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, NY, 1990, pp. 1-42.
42. G. Spenlehauer, M. Vert, J.P. Benoit, F. Chabot and M. Veillard, Biodegradable cisplatin microspheres prepared by the solvent evaporation method: morphology and release characteristics. J. Control. Release 7 (1988) 217.
43. L.R. Beck and V.Z. Pope, Controlled-release delivery systems for hormones. Drugs 270 (1984) 528.